September 9, then the wider pattern


PHINIA INC. did not wake up to a single stray sale. It woke up to a pattern. The latest filing came from Christopher Gustanski, the VP of Operational Excellence, who sold 2,097 shares on September 9 at an average price of $66.965, for roughly EUR 120,724 in euro-normalised filing value.
That is a modest ticket in isolation. It is not modest when you place it beside the rest of the quarter. CEO Brady D. Ericson sold 27,860 shares on August 31 for about $1.905 million, and the recent declaration list also includes sales by Samantha Pombier and Michael Coetzee in June, plus additional September filings from Todd L. Anderson, Chris P. Gropp, and Matthew Logar. Eight insiders trading the name in the same direction over the past quarter is the part that matters, because it turns a routine Form 4 into a cluster.
InsiderTrades data puts the historical T+90 cohort return for director-level buys at mid-cap names at 5.88%, with a 54.2% win rate across 5,309 cases. Useful context, yes. A forecast for PHINIA, no. The filing is the hook, not the thesis.
The stock is not being read in a vacuum. PHINIA sits in auto components, a corner of the market that has had to live with slower light-vehicle production in some regions, a choppy affordability backdrop, and the long grind of electrification. That mix has not killed the group, but it has kept valuations honest and made every incremental margin or demand update matter more than it used to.
PHINIA's own business mix gives you the tension. The company supplies fuel injection systems, electrical systems, and aftermarket solutions across internal combustion engine, hybrid, and alternative-fuel platforms in light vehicles, commercial vehicles, and industrial applications. That is a broad enough footprint to avoid being a one-note legacy supplier, but it still leaves the stock tied to propulsion demand that the market keeps re-rating. The company has tried to push the story toward aftermarket, aerospace and defense, and alternative fuels such as hydrogen and compressed natural gas. That is the right direction. It also means the market will keep asking whether those growth pockets are large enough to offset the old engine business as the cycle turns.
The peer set frames the issue cleanly. BorgWarner, Dana, and Garrett Motion all live in adjacent parts of the powertrain and components map, and all have had to answer the same question in different ways, which is how much value still attaches to traditional propulsion exposure when the market wants cleaner growth and cleaner end-demand visibility. PHINIA was spun out of BorgWarner in 2023, so the comparison is not academic. It is the family resemblance the market still uses when it prices the stock.
The cluster matters because it is not just one executive trimming a position after a run. The recent declarations show 12 filings over a short stretch, with six of the named insiders in the internal dossier all selling in September or late August. Todd L. Anderson, Chris P. Gropp, Matthew Logar, Gustanski, and the earlier Ericson sale all point the same way. That is a lot of supply for a stock that has already slipped below both its 50-day and 200-day moving averages.
The market has not been generous to the shares either. PHINIA closed at $66.24 on September 11, down about 4% over the prior week and roughly 10% over the prior month, while still trading inside a 52-week range of $50.80 to $86.94. The stock is not broken. It is not acting like a name that has found a clean bid either. When a cluster of insiders sells into that kind of tape, the filing does not need to be dramatic to matter.
There is a second layer here. The insider amounts are not huge relative to the company. Gustanski's sale was a negligible fraction of market value, and the internal score rationale notes that the filing value was near EUR 120,724. That keeps this from becoming a balance-sheet story or a governance alarm. But the market does not need a governance alarm to mark down a stock. It only needs a steady stream of supply from executives who know the cadence of the business better than the rest of us do.
Auto suppliers have been living through a valuation reset that is less about one quarter and more about the market's willingness to pay for exposure to the old drivetrain while the industry transitions. BorgWarner, Dana, and Garrett Motion all trade with that tension in the background. They are not the same business, but they share enough end-market DNA that the market tends to group them when it is deciding whether a rally is a rerating or just a bounce.
PHINIA's second-quarter numbers gave the stock some support on the operating side. The company reported net sales of $940 million, up 5.6% year over year, and adjusted EPS of $1.53, which beat consensus. Management also refined full-year 2026 guidance to net sales of $3.57 billion to $3.67 billion. That is not a weak operating print. It is the kind of update that should keep the stock from looking like a broken story. Yet the shares still slipped after the report, which tells you the market is not paying up for the beat in the way it might have a few years ago.
That disconnect is common in this group. A clean quarter helps, but it does not erase the structural debate around propulsion mix, aftermarket durability, and how much of the business can be re-rated as a transition beneficiary rather than a legacy supplier. PHINIA has tried to answer that by leaning into alternative fuels and adjacent end markets. The market will want to see that in the numbers, not in the slide deck.

InsiderTrades data does give PHINIA a useful frame, but only if you keep it in its lane. The internal score rationale points to three things that matter here: the filing came from an operating director, it sits inside a wide cluster of eight insiders trading the same name in the same direction over the past quarter, and the transaction size was tiny relative to market value. Those are the ingredients that make a filing worth reading, not a reason to pretend the stock is about to do something specific.
The strategy backdrop is there as well, but it belongs in the margin. Our framework uses a 90-day holding window, a maximum position size of 0.08, and the live out-of-sample headline currently reads 0.81, 26.4, and 51.5 on the restricted EU venue universe. That is a screening framework, not a promise, and it lives in a short, single-regime window. Useful for context. Not a substitute for reading the company.
PHINIA's fundamental profile is mixed rather than cleanly strong. The dossier shows a score of 57, with a value pillar at 71 and quality at 43. That is enough to say the business is not junk and not a pristine compounder. It is a mid-cap industrial with enough operating substance to matter, but not enough quality momentum to make insider selling easy to ignore. The market usually gives you some slack when quality is high. Here, it does not.
The chart is doing some of the work for the sellers. PHINIA closed below both its 50-day and 200-day moving averages, and the stock had already lost about 10% over the prior month. That matters because insider sales are rarely read in isolation when the price is already soft. A sale into strength can be shrugged off as portfolio management. A sale into weakness looks more like caution, even when the filing itself says nothing about motive.
The 52-week range also keeps the setup from being one-sided. At $66.24, the stock is well above the $50.80 low and still below the $86.94 high. So this is not a distressed equity and not a momentum darling. It is a mid-cap supplier in the middle of a valuation argument, with management still showing up in the filing record as sellers rather than buyers. That combination tends to keep the stock in a holding pattern until the market gets a cleaner operating catalyst.
The peer comparison matters again here. BorgWarner, Dana, and Garrett Motion all trade with their own versions of the same question, which is whether the market should pay for cash generation and transition optionality or keep discounting the legacy exposure. PHINIA's aftermarket push and alternative-fuel work are the right answers to that question, but the stock still has to prove that those businesses can carry more of the multiple than they do today.
The next useful data point is not another headline about insider activity. It is whether PHINIA can keep translating the second-quarter beat into a steadier operating narrative while the stock remains below its key moving averages. If the company keeps delivering revenue growth, holds the refined full-year guide, and shows that aftermarket and alternative-fuel exposure are doing real work, the market has a reason to look past the selling cluster. If not, the filings will keep reading as a steady drip of supply from a management team that is not rushing to add exposure at these levels.
The other thing to watch is whether the cluster broadens or fades. Eight insiders in the same direction over a quarter is already enough to notice. If that count stops there, the market can treat it as a concentrated period of profit-taking. If more names join in, the read gets less comfortable. That is especially true in a stock that has already slipped on the month and is trading under both major moving averages.
For now, the filing says this much. Christopher Gustanski sold 2,097 shares on September 9. Brady Ericson sold much more on August 31. The stock is still in the middle of a sector debate that has not gone away, and the next earnings update will matter more than the next round of commentary.
The filing trail is straightforward. The September 9 sale by Christopher Gustanski appears in the SEC Form 4 record, and the broader cluster is visible across the recent insider-trading pages and ownership summaries. The operating backdrop comes from PHINIA's second-quarter 2026 results and the company newsroom, while the price action and moving-average context come from market quote pages.
The important part is not the paperwork itself. It is the way the paperwork lands against a stock that has already softened, a peer group that still trades with propulsion-cycle baggage, and a company that is trying to prove its aftermarket and alternative-fuel work can matter more than the old engine exposure. That is the setup now, and the next quarter will tell you whether the market wants to pay for it.
This is not investment advice.
This is not investment advice.
Henlius directors sold a small EUR 16.3k cluster while Hong Kong biotech bounced. The stock still trails YTD, and the fi...
Applied Nutrition’s CEO and COO sold EUR 22.4m after three 2026 guidance lifts. The bull case is real, but so is the ins...
Applied Nutrition’s CEO-linked seller and COO sold EUR 22.4m after a strong FY26 upgrade. The sector is hot, but the tim...
NuScale Power fell 15.7% after UBS cut it to Sell. CFO Robert Ramsey Hamady’s August sale adds to a three-insider cluste...
BillionToOne’s September insider sales came as diagnostics stayed hot, peers traded unevenly, and the stock sat well bel...
ABC Arbitrage’s board-level selling cluster lands as ABCA trades near EUR 5.23, with sector flows, peers, and our cohort...